Ltd Neurodawn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

On February 19, 2024, the Journal of American Medical Association?Neurology published online the key findings of a phase III clinical study investigating Sanbexin® sublingual tablets for the.

United statesJournal of american medical associationSimcere pharmaceutical group ltdNeurodawn pharmaceutical coLtd neurodawnNational medical products administration of chinaAmerican medicalSimcere pharmaceutical groupNeurodawn pharmaceuticalDexborneol concentrated solutionNew drug applicationNational medical products administration